Issue link: https://www.e-digitaleditions.com/i/689532
Tablets & Capsules Solid Dosage SourceBook June 2016 33 GELITA Corporate Description/ Market Leadership GELITA® Gelatine is the foundation of the world's leading gelatin hard- and soft-capsules – the most popular dosage forms for prescription and over-the- counter drugs, dietary supplements, vitamins and minerals. GELITA is the global market leader in gelatine with global production and technical expertise since 1875. New Products GELITA's Pharmaceutical Competence Team continues to build upon its patented GELITA® RXL reduced cross- linking gelatine and technological know-how for improved capsule stability and shelf-life. GELITA is now offering a line extension to the GELITA® RXL capsule gelatine portfolio to include gelatine with specifically controlled and fast releasing properties. GELITA® RXL R 2 (R squared) Gelatine has been proven in independent capsule experiments to release fills significantly faster than standard gelatine capsules. Consumers may now benefit from the more immediate release of medications, such as sleep aids, allergy treatments, pain relievers and psychological aids. And, the capsule industry itself can likewise benefit from more advanced product differentiation with a capsule delivery system that is already widely preferred by consumers. Capsules featuring these advanced releasing properties can promote improved patient compliance for dosage forms that are simple and reliable to manufacture. GELITA 2445 Port Neal Industrial Rd. Sergeant Bluff, IA 51054 Tel: 712 943 5516 800 223 9244 Email: service.na@gelita.com Website: www.gelita.com Useful in all gelatine capsule formats, the GELITA® RXL portfolio is particularly useful in soft capsule (soft gel) formats and even accommodate higher pH capsule formulations. Removal of the cross-linking constraint combined with rapid releasing properties has opened a new field of capsule composition possibilities and formulators are rushing to take advantage of this new field – especially as the use of both GELITA® RXL and RXL R2 requires no processing or equipment investments. Best of all, the ingenuity of patented GELITA® RXL Gelatines (US patent 7,485,323) is accomplished without any non-gelatine additives and complies with existing regulations. These optimized gelatines support Quality by Design initiatives for new drug developments, speeding product development by reducing the possibility that a capsule formulation, once developed, will later fail storage requirements. GELITA® RXL and RXL R 2 can also reduce the level of Tier 2 testing required. New Products / Novel Delivery Aside from expertise in gelatine for capsules, GELITA also offers unique, customized gelatines for gummy delivery systems - whether for vitamin, mineral or dietary supplement formulations. Consider partnering with GELITA to participate in the rapidly expanding fortified gummy market! Global Scope As a global supplier, GELITA offers gelatine for standard hard- and soft- capsules from numerous global manufacturing sites and from multiple raw material types. And, for increased marketability, GELITA, in collaboration with Geliko LLC, offers the first commercially available kosher gelatine. Geliko® Kosher Gelatine (certified by the Orthodox Union) features the same versatility and functionality as its non- kosher counterparts; but adds value with the OU kosher certification.